STAA on Nasdaq

STAAR SURGICAL CO

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye.5 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

$239.4MRevenue, fiscal 20263
-$80.4MNet income, fiscal 20263

Compare with RxSight, Inc., Warby Parker or National Vision Holdings, Inc., or pick any stock.

  • TickerSTAA on Nasdaq2
  • IndustryOphthalmic Goods2
  • HeadquartersMonrovia, United States2
  • Incorporated inDE4
  • Business address1911 Walker Ave, Monrovia, Ca 910164
  • Filer categoryLarge accelerated filer4
  • Legal formCorporation2
  • LEI5299006LRHI7OJ8BY3082
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressc/o Corporation Service Company, 251 Little Service Company, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 20874872

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. We are the leading manufacturer of phakic implantable lenses used worldwide in corrective or “refractive” surgery. We have been dedicated solely to ophthalmic surgery for over 40 years. Our goal is to position our refractive lenses throughout the world as primary and premium solutions for patients seeking visual freedom from wearing eyeglasses or contact lenses while achieving excellent visual acuity through refractive vision correction. Unless the context indicates otherwise, “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

76.2%Gross margin3
-38.3%Operating margin3
-33.6%Net margin3
-23.4%Return on equity3
-$40.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue15¢$57.0M
  • Research and development11¢$40.1M
  • Selling, general and admin73¢$274.1M
  • Income tax0¢$1.8M

Out of $239.4M in revenue.3 The company lost money this year.

Financial statements

Revenue673$239.4M in 2026+1048% since 2020
0$100.0M$200.0M$300.0M$400.0M2020: $20.9M$20.9M20202021: $230.5M$230.5M2021+1005%2022: $239.4M$239.4M2022+4%2023: $322.4M$322.4M2023+35%2024: $313.9M$313.9M2024−3%2026: $239.4M$239.4M2026−24%
Gross profit8793$182.4M in 2026+63% since 2020
0$100.0M$200.0M$300.0M2020: $112.0M$112.0M20202021: $178.6M$178.6M2021+60%2022: $223.4M$223.4M2022+25%2023: $252.7M$252.7M2023+13%2024: $239.6M$239.6M2024−5%2026: $182.4M$182.4M2026−24%
Operating income8793-$91.7M in 2026
-$100.0M-$50.0M0$50.0M2020: $11.9M$11.9M20202021: $33.3M$33.3M2021+181%2022: $43.8M$43.8M2022+31%2023: $28.1M$28.1M2023−36%2024: -$12.6M-$12.6M20242026: -$91.7M-$91.7M2026+627%
Net income8793-$80.4M in 2026
-$100.0M-$50.0M0$50.0M2020: $14.0M$14.0M20202021: $27.5M$27.5M2021+96%2022: $39.7M$39.7M2022+44%2023: $21.3M$21.3M2023−46%2024: -$20.2M-$20.2M20242026: -$80.4M-$80.4M2026+298%
Fiscal year20192020202120222023202420252026
Revenue$20.9M6$230.5M7$239.4M3$322.4M3$313.9M3$239.4M3
Cost of revenue$38.2M8$51.8M7$61.0M9$69.8M3$74.3M3$57.0M3
Gross profit$112.0M8$178.6M7$223.4M9$252.7M3$239.6M3$182.4M3
Research and development$25.3M8$33.9M7$36.0M9$40.5M3$45.3M3$40.1M3
Selling, general and admin$100.1M8$145.3M7$179.6M9$224.6M3$252.2M3$274.1M3
Operating income$11.9M8$33.3M7$43.8M9$28.1M3-$12.6M3-$91.7M3
Interest
Income before tax$31.3M7$45.6M9$33.7M3-$9.1M3-$82.3M3
Income tax-$1.0M8$3.8M7$5.9M9$12.3M3$11.2M3-$1.8M3
Net income$14.0M8$27.5M7$39.7M9$21.3M3-$20.2M3-$80.4M3
Earnings per share$0.328$0.587$0.839$0.443-$0.413-$1.623
Earnings per share (diluted)$0.308$0.567$0.809$0.433-$0.413-$1.623
Shares (weighted, basic)47.2M shares748.0M shares948.5M shares349.1M shares349.6M shares3
Shares (weighted, diluted)49.5M shares749.4M shares949.4M shares349.1M shares349.6M shares3

Compare STAAR SURGICAL CO with another company

Leadership

Who has led STAAR SURGICAL CO, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (47)

Former names

  • STAAR SURGICAL COMPANYAug 10, 1995 to Aug 17, 20044

Timeline

  1. Feb 4, 2026New chief executive Deborah J. Andrews becomes CEO16
  2. Feb 4, 2026New chief executive Warren Foust becomes CEO17
  3. Feb 28, 2025New chief executive Stephen C. Farrell becomes CEO18
  4. Jan 4, 2023New chief executive Thomas G. Frinzi becomes CEO19
  5. Mar 4, 2015New chief executive Caren L. Mason becomes CEO20
  6. Jan 10, 2008New chief executive Barry G. Caldwell becomes CEO21

Filings

433 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 86 major events, 174 insider forms, 52 large holders, 101 other. The latest 20:

  1. Oct 5, 20268-K/A EDGAR
  2. Sep 10, 20268-K EDGAR
  3. Aug 18, 20264 EDGAR
  4. Aug 18, 20264 EDGAR
  5. Aug 18, 20264 EDGAR
  6. Aug 14, 2026SCHEDULE 13G/A EDGAR
  7. Aug 12, 202610-Q EDGAR
  8. Aug 12, 20268-K EDGAR
  9. Aug 6, 20268-K EDGAR
  10. Aug 4, 20264 EDGAR
  11. Aug 4, 20264 EDGAR
  12. Jun 24, 2026S-8 EDGAR
  13. Jun 23, 20264 OWNERSHIP DOCUMENT EDGAR
  14. Jun 22, 20264 EDGAR
  15. Jun 22, 20264 EDGAR
  16. Jun 22, 20264 EDGAR
  17. Jun 22, 20264 EDGAR
  18. Jun 22, 20264 EDGAR
  19. Jun 22, 20264 EDGAR
  20. Jun 22, 20268-K EDGAR

The 433 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

83 open-market trades by officers, directors and large owners since October 2021: 70 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 13, 2026BROADWOOD CAPITAL INC10% ownerBuy316,017$18.62$5.9MForm 4
Mar 12, 2026BROADWOOD CAPITAL INC10% ownerBuy299,432$18.12$5.4MForm 4
Mar 11, 2026BROADWOOD CAPITAL INC10% ownerBuy54,764$17.52$959.5KForm 4
Jan 9, 2026Bradsher Neal CDirectorBuy27,485$22.05$606.0KForm 4
Jan 8, 2026Bradsher Neal CDirectorBuy3,240$21.94$71.1KForm 4
Jan 7, 2026Bradsher Neal CDirectorBuy66,467$22.00$1.5MForm 4
Jan 6, 2026Bradsher Neal CDirectorBuy336,946$21.62$7.3MForm 4
Nov 21, 2025Bradsher Neal CDirectorBuy797,486$27.86$22.2MForm 4
Nov 20, 2025Bradsher Neal CDirectorBuy393,382$27.14$10.7MForm 4
Nov 19, 2025Bradsher Neal CDirectorBuy309,132$26.42$8.2MForm 4
Apr 10, 2025Bradsher Neal CDirectorBuy900$15.18$13.7KForm 4
Apr 9, 2025Bradsher Neal CDirectorBuy8,200$15.08$123.7KForm 4
Apr 8, 2025Bradsher Neal CDirectorBuy178,127$15.32$2.7MForm 4
Apr 7, 2025BROADWOOD PARTNERS, L.P.DirectorBuy138,054$15.61$2.2MForm 4
Apr 4, 2025BROADWOOD PARTNERS, L.P.DirectorBuy497,631$15.91$7.9MForm 4
Apr 3, 2025BROADWOOD PARTNERS, L.P.DirectorBuy209,535$16.97$3.6MForm 4
Apr 2, 2025BROADWOOD PARTNERS, L.P.DirectorBuy31,780$17.43$553.9KForm 4
Mar 31, 2025BROADWOOD PARTNERS, L.P.DirectorBuy22,189$17.46$387.4KForm 4
Mar 28, 2025Bradsher Neal CDirectorBuy8,131$17.47$142.0KForm 4
Mar 27, 2025Bradsher Neal CDirectorBuy3,620$17.48$63.3KForm 4

All 83 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Broadwood Capital Inc16,123,842$462.6M24.2%No change
BlackRock, Inc.6,731,154$193.1M0.0%+65,036
Madison Avenue Partners, LP4,175,748$119.8M5.2%+1,734,070
Yunqi Capital Ltd3,257,130$93.4M74.8%No change
Point72 Asset Management, L.P.2,437,446$69.9M0.1%+1,614,294
Goldman Sachs Group Inc2,150,809$61.7M0.0%+1,080,870
Vanguard Portfolio Management LLC1,979,573$56.8M0.0%−144,016
State Street Corp1,769,354$50.8M0.0%−63,642
Anatole Investment Management Ltd1,651,701$47.4M8.0%+50,000
Vanguard Capital Management LLC1,552,743$44.5M0.0%−137,863
Morgan Stanley1,316,119$37.8M0.0%−183,237
Geode Capital Management, LLC1,076,006$30.9M0.0%+59,502
Two Seas Capital LP1,064,389$30.5M1.2%+27,416
Dimensional Fund Advisors LP867,142$24.9M0.0%+46,360
American Capital Management Inc846,659$24.3M1.1%−31,376
AI-Squared Management Ltd542,420$15.6M8.3%+274,336
Charles Schwab Investment Management Inc445,713$12.8M0.0%+37,137
Defender Capital, LLC.431,187$12.4M4.0%−213,355
Northern Trust Corp423,112$12.1M0.0%+22,894
Norges Bank365,200$10.5M0.0%New
UBS Group AG341,183$9.8M0.0%+161,254
Renaissance Technologies LLC340,400$9.8M0.0%+205,200
Defilade Capital Management, L.P.322,126$9.2M1.2%New
Vanguard Fiduciary Trust Co322,004$9.2M0.0%−66
Principal Financial Group Inc241,976$6.9M0.0%+1

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86